China Universal Asset Management »

Artiva Biotherapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Artiva Biotherapeutics (ARTV) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Artiva Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Artiva Biotherapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Artiva Biotherapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $12k 4.3k 2.87
2025-06-30 $7.4k 4.9k 1.51
2025-03-31 $15k 4.9k 3.00
2024-12-31 $52k 5.2k 10.08

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Alphabet Inc-cl A Common Stock (GOOGL)
Meta Platforms Inc-class A Common Stock (META)
Netflix Common Stock (NFLX)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Gilead Sciences Common Stock (GILD)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl C Common Stock (GOOG)
Palantir Technologies Inc-a Common Stock (PLTR)
Applovin Corp-class A Common Stock (APP)

View all positions for China Universal Asset Management

Top funds holding Artiva Biotherapeutics

RA Capital Management
5AM Venture Management
VR Adviser
venBio Partners
Citadel Advisors
Franklin Resources
BlackRock
Millennium Management
Wellington Management Company
Vanguard Group
Bnp Paribas Arbitrage, Snc
Geode Capital Management
Alyeska Investment Group
Renaissance Technologies
State Street Corporation

View all funds holding Artiva Biotherapeutics